• Narmeen Salih Ahmad Kurdistan Institution for Strategic Studies and Scientific Research, Sulaimani, Kurdistan Region, Iraq.
  • Hersh Abdul Ham Karim College of Medicine, Komar University of Science and Technology, Chaq-Chaq-Qualaraisi, Sulaimani, Kurdistan Region, Iraq.
  • Luqman Khalid Rasool Hiwa Cancer Hospital, Thalassemia and Congenital Blood Disorders Center, Sulaimani, Kurdistan Region, Iraq.
  • Khanzad Ahmed Ali Kurdistan Institution for Strategic Studies and Scientific Research, Sulaimani, Kurdistan Region, Iraq.
  • Mohammed Abdalla Mahmood Dental Basic Science Department, College of Dentistry, University of Sulaimani, Kurdistan Region, Iraq.
  • Tara Jamel Osman Hiwa Cancer Hospital, Thalassemia and Congenital Blood Disorders Center, Sulaimani, Kurdistan Region, Iraq.
  • Chawan Wrya Hamakhan Kurdistan Institution for Strategic Studies and Scientific Research, Sulaimani, Kurdistan Region, Iraq.




β-Thalassemia, Mutation, Beta globin gene, Polymerase chain reaction, Sanger sequencing


β-thalassemia is a most common hereditary disease where the patients suffer from decreased or absence of beta-globin chain synthesis, which leads to hemolytic anaemia and other complications. Very little data about beta-globin mutations in the Kurdish population is available to date.

This study aimed to provide a more precise picture of the β-thalassemia mutations spectrum and to estimate their frequencies.

A cohort of 100 β-thalassemia patients was tested to detect mutations in the beta-globin gene’s regions (3 exons and two introns) using molecular techniques (polymerase chain reaction and Sanger sequencing).

In this study, a total of 31 beta-thalassemia mutations were identified. The results showed that IVSII-666 C>T and IVSII-16 G>C were predominant over other mutations, with 59% of thalassemic patients having these mutations. Other common mutations found, in order of decreasing frequency, were Cd2 T>C, IVSII-74 T>G, IVS1-110 G>A, IVSI-5 G>C, IVSII-1 G>A, IVSII-81 C>T. The remaining mutations were uncommon and accounted for a few cases. More importantly, five novel beta-thalassemia mutations, namely, IVSII-13
G>A, IVSII-14 A>C, IVSII-17 delC, IVSII-68_69 dupG, and Cd2/3 +C, were discovered which have not been previously reported in other populations.

The results obtained in this study can be used as a guide before prenatal diagnosis and during premarital screening of β-thalassemia in the Kurdish population.


Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010;5(1):1–15.

Boonyawat. B, Monsereenusorn. C, Traivaree. C. Molecular analysis of beta-globin gene mutations among Thai beta-thalassemia children : results from a single centre study. Appl Clin Genet. 2014;7:253–8.

Elizabeth G, Ann MTJA. Genotype-phenotype diversity of beta-thalassemia in Malaysia: Treatment options and emerging therapies. Med J Malaysia. 2010;65(4):256–60.

Sadiq MF, Eigel A, Horst J. Spectrum of β-thalassemia in Jordan: Identification of two novel mutations. Am J Hematol. 2001;68(1):16–22.

Xu L, Chen M, Huang H, Lin N, Chen L, Wang Y, et al. Identification of a novel pre-terminating mutation in human HBB gene as a cause of beta(0)-thalassemia phenotype. Int J Clin Exp Pathol. 2019;12(8):3070–6.

Maskoen AM, Rahayu NS, Reniarti L, Susanah S, Laksono B, Fauziah PN, et al. Mutation spectrum of β-globin gene in thalassemia patients at Hasan Sadikin Hospital - West Java Indonesia. Cell Mol Biol. 2017;63(12):22–4.

Kumar R, Arya V, Agarwal S. Profiling β Thalassemia Mutations in Consanguinity and Nonconsanguinity for Prenatal Screening and Awareness Programme. Adv Hematol. 2015;2015.

Mirasena S, Shimbhu D, Sanguansermsri M. The Spectrum of β-thalassemia Mutations in Phitsanulok Province : Development of Multiplex ARMS for Mutation Detection. Naresuan Univ J [Internet]. 2007;15(1):43–53. Available from: www.PrimerBiosoft.com.

Al-Allawi NAS, Hassan KMA, Sheikha AK, Nerweiy FF, Dawood RS, Jubrael J. -Thalassemia Mutations among Transfusion-Dependent Thalassemia Major Patients in Northern Iraq. Mol Biol Int. 2010;2010:1–4.

Saleh K, Kakey E. Some Molecular Characterisation of βeta-Thalassemia Major In Koya City. 2018; International Conference on Pure and Applied Sciences (ICPAS):64–8.

Abdaoui W, Benouareth DE, Djenouni A, Renoux C, Grifi F, Gouri A, et al. Genetic Background of β-Thalassemia in Northeast Algeria with Assessment of the Thalassemia Severity Score and Description of a new β0-ThalassemiaFrameshift Mutation (HBB: c.374dup; p.Pro126Thrfs*15). Hemoglobin. 2019;43(4–5):223–8.

Chibani J, Vidaud M, Duquesnoy P, Bergé-Lefranc JL, Pirastu M, Ellouze F, et al. The peculiar spectrum of β-thalassemia genes in Tunisia. Hum Genet. 1988;78(2):190–2.

Al-thwaini AN, Hussain AS. BETA-THALASSEMIA MAJOR IN SOME IRAQI. 2010;9(1):115–23.

Ahmed D. Jabbar, Safaa A. Faraj MD JNJA. Molecular Characterisation of β -Thalassemia Patients in Wasit Province, IRAQ Molecular Characterization of β-Thalassemia Patients in Wasit. 2016;6(October):59–65.

H. H. Ince, O. Ayyildiz, S. Kalkanli, S. Batun and E, Muftuoglu. Molecular basis of β-thalassemia mutations in Diyarbakir in the southeastern region of Turkey. Hemoglobin. 2003;27(4):275–8.

M. A. Hosseinpour Feizi, A. A. Hosseinpour Feizi NP, M. Haghi and PA. Molecular spectrum of βthalassemia mutations in Northwestern Iran. Hemoglobin. 2008;32(3):255–61.

M. Haghi, S. Khorshidi, M. A. H. Feizi, N. Pouladi A, HosseinpourFeizi AA. β-thalassemia mutations in the Iranian Kurdish population of Kurdistan and West Azerbaijan provinces. Hemoglobin. 2009;33(2):109–14.

Chouk I, Daoud B Ben, Mellouli F, Bejaoui M, Gérard N, Dellagi K, et al. Contribution to describing the β-thalassemia spectrum in Tunisia and the origin of mutation diversity. Hemoglobin. 2004;28(3):189–95.

Zahed L. The spectrum of β-thalassemia mutations in the Arab populations. J Biomed Biotechnol. 2001;2001(3):129–32.

Al-Badran AI, Hassan MK, Washil AF. β-Thalassemia Mutations among Thalassemia Major Patients in Basrah Province – Iraq. Int J Curr Microbiol Appl Sci. 2016;5(5):448–57.

Abdelaziz Omer W. Molecular characterisation of betathalassemia mutations in Ninawa governorate. Ann Coll Med Mosul. 2009;35(2):124–33.

Aziz Dhaka Shishu Hospital A, Khan W, Ferdoushi A. Molecular Analysis of Hb-E and Beta-Thalassemia Major Patients among Bangladeshi Population. Austin J Biotechnol Bioeng [Internet]. 2017;4(4):1-4

Sima MD, Aziz Kh, Abbasali HPF, Mahmoud Sh. Spectrum of β-Globin Gene Mutations and β-Thalassemia Haplotype Analysis among the Iranian Azeri Turkish Population. Epidemiol Open Access. 2015;05(04):0–7.

Nezhad FH, Nezhad KH, Choghakabodi PM, Keikhaei B. Prevalence and genetic analysis of α- And β-thalassemia and sickle cell anaemia in southwest Iran. J Epidemiol Glob Health. 2018;8(3–4):189–95.

Miri-Moghaddam E, Zadeh-Vakili A, Nikravesh A, Sanei Sistani S, Naroie-Nejad M. Sistani population: A different spectrum of β-Thalassemia mutations from other ethnic groups of Iran. Hemoglobin. 2013;37(2):138–47.

Saleh-Gohari N, Bazrafshani MR. Distribution of β-globin gene mutations in thalassemia minor population of Kerman province, Iran. Iran J Public Health. 2010;39(2):69–76.

Jeddoa ZMA, Al-murrani WK, Ali NA, Al-zaag AA, Houshmand M. Molecular. Detection of Some Mutations Associated with Βeta-Thalassaemia in Iraq. Iraqi Academic Scientific Journals. 2(4): 263-274

AlAllawai NAS, Jalal SA, Mohammad AM, Omer ShQ, Markous RSD. β-thalassemia intermedia in Northern Iraq: a single centre experience. Bio Med Research International. 2014. https://doi.org/10.1155/2014/262853

Amin SS, Jalal SD, Ali KM, Mohammed AI, Rasool LK, Osman TJ. Beta-Thalassemia Intermedia: A Single Thalassemia Center Experience from Northeastern Iraq. BioMed Research International. 2020. https://doi.org/10.1155/2020/2807120

Al-Allawi NAS, Jalal SD, Ahmed NH, Faraj AH, Shalli A, Hamamy H. The first five years of a preventive programme for haemoglobinopathies in Northeastern Iraq. J Med Screen. 2013. 20(4) 171–176



How to Cite

Ahmad N, Karim H, Rasool L, Ali K, Mahmood M, Osman T, et al. A SPECTRUM OF Β-THALASSEMIA MUTATIONS IN SULAIMANI PROVINCE OF IRAQ: IDENTIFICATION OF NOVEL MUTATIONS. JSMC [Internet]. 2023 Dec. 21 [cited 2024 Apr. 23];13(4):7. Available from: https://jsmc.univsul.edu.iq/index.php/jsmc/article/view/jsmc-10435

Similar Articles

1-10 of 36

You may also start an advanced similarity search for this article.